All Relations between Schizophrenia and hippocampus

Publication Sentence Publish Date Extraction Date Species
Snezana Kusljic, Maarten van den Buus. Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats. The European journal of neuroscience. vol 20. issue 12. 2005-02-15. PMID:15610175. these results suggest that serotonin projections from the median raphe nucleus to the dorsal hippocampus play an important role in locomotor hyperactivity and prepulse inhibition in rats, animal models of aspects of schizophrenia. 2005-02-15 2023-08-12 rat
Lise Rioux, Delta Ruscheinsky, Steven Edward Arnol. Microtubule-associated protein MAP2 expression in olfactory bulb in schizophrenia. Psychiatry research. vol 128. issue 1. 2005-02-08. PMID:15450909. we investigated the expression in the ob of the microtubule-associated protein map2, which has been shown to be abnormally expressed in the hippocampal region in schizophrenia. 2005-02-08 2023-08-12 human
Michael W Jan. Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis. Pharmacotherapy. vol 24. issue 12. 2005-01-26. PMID:15585443. positron emission tomography, functional magnetic resonance imaging, and proton magnetic spectroscopy studies have shown that prefrontal cortex and hippocampus activity and cell density are lower in patients with schizophrenia than in healthy controls. 2005-01-26 2023-08-12 Not clear
François Laplante, Carl W Stevenson, Alain Gratton, Lalit K Srivastava, Rémi Quirio. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex. Journal of neurochemistry. vol 91. issue 6. 2005-01-21. PMID:15584923. excitotoxic neonatal ventral hippocampus (nvh) lesions in rats result in characteristic post-pubertal hyper-responsiveness to stress and cognitive abnormalities analogous to those described in schizophrenia and suggestive of alterations in dopamine (da) neurotransmission. 2005-01-21 2023-08-12 rat
Sabina Berretta, Nicholas Lange, Sujoy Bhattacharyya, Ronnie Sebro, Jessica Garces, Francine M Bene. Long-term effects of amygdala GABA receptor blockade on specific subpopulations of hippocampal interneurons. Hippocampus. vol 14. issue 7. 2005-01-14. PMID:15382257. in particular, changes in specific interneuronal markers within selective hippocampal sectors detected in the present results are strikingly similar to those reported in this region in schizophrenia. 2005-01-14 2023-08-12 rat
James M Gold, Michael S Poet, Christopher M Wilk, Robert W Buchana. The family pictures test as a measure of impaired feature binding in schizophrenia. Journal of clinical and experimental neuropsychology. vol 26. issue 4. 2004-12-30. PMID:15512938. such feature binding deficits likely implicate hippocampal dysfunction, consistent with neuroimaging evidence of structural and functional compromise of the medial temporal lobe in schizophrenia. 2004-12-30 2023-08-12 Not clear
Colin P Mitchell, Morris B Goldma. Neonatal lesions of the ventral hippocampal formation disrupt neuroendocrine responses to auditory stress in the adult rat. Psychoneuroendocrinology. vol 29. issue 10. 2004-12-14. PMID:15288711. we posit that clarification of how nvhfl alters relatively "simple", well characterized, and phylogenetically preserved systems, such as the neuroendocrine system, may provide insight into the mechanism of hippocampal pathology in schizophrenia. 2004-12-14 2023-08-12 rat
P Sachdev, H Brodaty, D Cheang, S Cathcar. Hippocampus and amygdala volumes in elderly schizophrenic patients as assessed by magnetic resonance imaging. Psychiatry and clinical neurosciences. vol 54. issue 1. 2004-12-07. PMID:15558887. reduced size of the hippocampus and amygdala has been one of the more consistent morphological findings in schizophrenia, but the question of medial temporal abnormalities in elderly schizophrenia patients has been inadequately addressed. 2004-12-07 2023-08-12 human
P Sachdev, H Brodaty, D Cheang, S Cathcar. Hippocampus and amygdala volumes in elderly schizophrenic patients as assessed by magnetic resonance imaging. Psychiatry and clinical neurosciences. vol 54. issue 1. 2004-12-07. PMID:15558887. for the schizophrenia group, there were significant correlations between amygdala and hippocampus volumes and some neuropsychological performance indices. 2004-12-07 2023-08-12 human
Martin Styner, Jeffrey A Lieberman, Dimitrios Pantazis, Guido Geri. Boundary and medial shape analysis of the hippocampus in schizophrenia. Medical image analysis. vol 8. issue 3. 2004-12-02. PMID:15450215. boundary and medial shape analysis of the hippocampus in schizophrenia. 2004-12-02 2023-08-12 Not clear
Martin Styner, Jeffrey A Lieberman, Dimitrios Pantazis, Guido Geri. Boundary and medial shape analysis of the hippocampus in schizophrenia. Medical image analysis. vol 8. issue 3. 2004-12-02. PMID:15450215. this paper describes a combined boundary and medial shape analysis based on two different shape descriptions applied to a study of the hippocampus shape abnormalities in schizophrenia. 2004-12-02 2023-08-12 Not clear
Stephan Hecker. The hippocampus in schizophrenia. The American journal of psychiatry. vol 161. issue 11. 2004-12-02. PMID:15514431. the hippocampus in schizophrenia. 2004-12-02 2023-08-12 Not clear
Amanda J Law, Cynthia Shannon Weickert, Thomas M Hyde, Joel E Kleinman, Paul J Harriso. Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. The American journal of psychiatry. vol 161. issue 10. 2004-11-16. PMID:15465982. aberrant synaptic connectivity may underlie the involvement of the hippocampus in schizophrenia. 2004-11-16 2023-08-12 Not clear
Amanda J Law, Cynthia Shannon Weickert, Thomas M Hyde, Joel E Kleinman, Paul J Harriso. Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. The American journal of psychiatry. vol 161. issue 10. 2004-11-16. PMID:15465982. this study tested the hypothesis that hippocampal dendritic pathology is also present in schizophrenia. 2004-11-16 2023-08-12 Not clear
Joseph I Friedma. Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists. Psychopharmacology. vol 174. issue 1. 2004-10-25. PMID:15205878. alterations in the central cholinergic system of patients with schizophrenia such as reduced numbers of muscarinic and nicotinic receptors in the cortex and hippocampus may contribute to the cognitive impairment of schizophrenia. 2004-10-25 2023-08-12 Not clear
Laura F Martin, William R Kem, Robert Freedma. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology. vol 174. issue 1. 2004-10-25. PMID:15205879. this inhibitory process, which involves the alpha(7) nicotinic receptor mediated release of gamma-aminobutyric acid (gaba) by hippocampal interneurons, represents a potential new target for therapeutic intervention in schizophrenia. 2004-10-25 2023-08-12 Not clear
Paul J Harriso. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology. vol 174. issue 1. 2004-10-25. PMID:15205886. the hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. 2004-10-25 2023-08-12 Not clear
Paul J Harriso. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology. vol 174. issue 1. 2004-10-25. PMID:15205886. this paper puts the case for the hippocampus as being central to the neuropathology and pathophysiology of schizophrenia. 2004-10-25 2023-08-12 Not clear
Paul J Harriso. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology. vol 174. issue 1. 2004-10-25. PMID:15205886. hippocampal pathology in schizophrenia may be due to genetic factors, aberrant neurodevelopment, and/or abnormal neural plasticity; it is not due to any recognised neurodegenerative process. 2004-10-25 2023-08-12 Not clear
Paul J Harriso. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology. vol 174. issue 1. 2004-10-25. PMID:15205886. hippocampal involvement is likely to be associated with the neuropsychological impairments of schizophrenia rather than with its psychotic symptoms. 2004-10-25 2023-08-12 Not clear